ONE-CARBON METABOLISM AND CHEMOTHERAPY-INDUCED TOXICITIES IN PATIENTS WITH STAGE II-III COLORECTAL CANCER: A PROSPECTIVE COHORT STUDY
{{output}}
Introduction: One-carbon metabolism (OCM) is a target of the chemotherapeutic agent capecitabine. We investigated OCM biomarker concentrations in relation to capecitabine-induced toxicities in patients with stage II-III colorecta... ...
